Cross-border early-stage VC for medtech, mobility, deep tech with offices in US, UK, Luxembourg, Beijing, Singapore; cumulative $1.361B+ across Fund I ($570M deployed) + Fund II ($791M oversubscribed); >$100M returns and top quartile performance
No detailed funding rounds available.
Total known funding:
